Screener
Incyte INCY Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Incyte in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Incyte’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000879169-26-000056
| Line item | June 30,2026 | December 31,2025* |
|---|---|---|
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: | ||
| Preferred Stock, $0.001 par value; 5,000,000 shares authorized; none issued or outstanding | — | — |
| Common Stock, $0.001 par value; 400,000,000 shares authorized; 200,977,687 and 198,460,009 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 201 | 198 |
| Additional paid-in capital | 5,221,804 | 4,928,049 |
| Accumulated other comprehensive income | 19,718 | 25,462 |
| Retained earnings | 1,102,704 | 213,769 |
| Total stockholders’ equity | 6,344,427 | 5,167,478 |
Item 1. Financial Statements
FAQ
- What is Incyte's common stock, par value (in dollars per share)?
- Incyte (INCY) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
- How has Incyte's common stock, par value (in dollars per share) changed year-over-year?
- Incyte's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Incyte's common stock, par value (in dollars per share)?
- Over 4 years (2021 to 2025), Incyte's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
Ask your AI about Incyte's common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude